Daniel Choi in New York, New York

Home New York New York

Daniel Choi has Surgical Oncology as his primary medical specialty. Their primary office is: 1275 York Ave in New York, New York. There is an additional office location, for a total of two, for Daniel Choi that can be viewed further down.

They're a part of the: Mskcc Surgery Group medical group which has around 271 members. You can call their office at 212-639-2000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Chicago, Pritzker School Of Medicine and graduated in 2006 (around 18 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Daniel X Choi Office Phone and Directions

Daniel Choi
Mskcc Surgery Group
1275 York Ave
New York, New York 10065
212-639-2000

Patient Ratings
Please rate your experience with Daniel Choi below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 212-639-2000

Enter a starting address:

Healthcare Info for Daniel Choi

Additional Medical Specialties Include:
GENERAL SURGERY

Medical School: University Of Chicago, Pritzker School Of Medicine
Graduation Year: 2006
The Primary Medical Specialty for Daniel Choi is listed as: Surgical Oncology
Approximate Years of Experience: 18
PAC (PECOS ID)#: 4082925359
NPI #: 1992718092
NPI Created On: 08/13/2006
NPI Last Updated Listed as: 05/04/2022
Primary Taxonomy Code: 208600000X
License Number:
260104
Listed Gender: Male

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 843651097

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: LIBTAYO

Open Associated Drug #1: 61755-008-01